Case Report

Pericardial Involvement in Hereditary Hemorrhagic Telangiectasia

Abstract

Hereditary haemorrhagic telangiectasia is a rare disease characterized by cutaneo-mucous and visceral arteriovenous malformations. Cardiac involvement is uncommon and was presented primarily by hyper-output heart failure. Hemorrhagic pericardial effusion, although is extremely rare, can occur during HHT. We report the case of a 48-years-old woman which was hospitalized in 2015 in internal medicine department, Sfax, Tunisia in 2015 for anicteric cholestasis. She noticed a personnel and familial history of recurrent epistaxis. Biologic findings revealed anemia and moderate cholestasis. Viral investigations and immunologic tests were negative. Abdominal tomography showed multiple arterio-venous shunts of the liver. Liver involvement due to Rendu Osler Weber disease was retained. She was treated by ferrous iron, but she was lost to follow up. She was presented in February 2021, with severe anemia (5 g/dL). Physical examination revealed signs of global heart failure. Biological investigations found anemia, inflammatory biological syndrome, cytolysis and cholestasis. Heart ultrasound revealed an abundant pericardial effusion. Only 500cc of hemorrhagic fluid could be aspirated before the needle became blocked. Unfortunately, one week after, re-accumulation of pericardial fluid and worsening occurred. She underwent a partial surgical pericardial excision with pleuropericardial opening. Analysis of the fluid ruled out any infectious cause of this effusion.  Histological examination confirmed the vascular dysplasia with signs of hemorrhage and inflammation. The patient was discharged 1 month after surgery with no other bleeding episodes. For her anemia, she received a transfusion of red blood cells. Then, the patient was treated by iron treatment.

1. McDonald J, Pyeritz RE. Hereditary Hemorrhagic Telangiectasia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999;104:1343‑51.
3. Jackson SB, Villano NP, Benhammou JN, Lewis M, Pisegna JR, Padua D. Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature. Dig Dis Sci 2017;62:2623‑30.
4. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia. J Hepatol 2007;46:499-507.
5. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (RenduOsler-Weber syndrome). Am J Med Genet 2000;91:66-7.
6. Geisthoff UW, Nguyen HL, Röth A, Seyfert U. How to manage patients with hereditary haemorrhagic telangiectasia. Br J Haematol 2015;171:443-52.
7. Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc 1999;74:671‑80.
8. Mohamed S. Maladie de Rendu-Osler-Weber : lésions vasculaires hépatiques et hyperdébit cardiaque. Journal des Maladies Vasculaires 2015;40 :309-10.
9. Vorselaars VM, Velthuis S, Snijder RJ. Pulmonary hypertension in hereditary haemorrhagic telangiectasia. World J Cardiol 2015;7:230-7.
10. Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 2012;307:948-55
11. Hsi DH, Ryan GF, Hellems SO, Cheeran DC, Sheils LA. Large aneurysms of the ascending aorta and major coronary arteries in a patient with hereditary hemorrhagic telangiectasia. Mayo Clin Proc 2003;78:774-6.
12. Mieghem CA, Ligthart JM, Cademartiri F. Images in cardiology. Spontaneous dissection of the left main coronary artery in a patient with Osler-Weber-Rendu disease. Heart 2006;92:394.
13. Kanna B, Das B. Hemorrhagic Pericardial Effusion Causing Pericardial Tamponade in Hereditary Hemorrhagic Telangiectasia. Am J Med Sci 2004;327:149‑51.
14. Kopel L, Lage SG. Cardiac tamponade in hereditary hemorrhagic telangiectasia. Am J Med 1998;105:252‑3.
15. Chung JS, Bylsma R, Denham LJ, Hu H, Mamdani N, Bharadwaj A, et al. Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia. J Cardiothorac Surg 2022;44.
Files
IssueVol 62 No 5 (2024) QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/acta.v62i5.17778
Keywords
Rendu osler disease Cardiac involvement Pericardial effusion Tamponade

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Derbel A, Snoussi M, Ben Salah R, Frikha F, Abid L, Frikha I, Marzouk S, Bahloul Z. Pericardial Involvement in Hereditary Hemorrhagic Telangiectasia. Acta Med Iran. 2025;62(5):290-294.